Loading stock data…
$0.87-0.01 (-0.57%)
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.
Rapid Micro Biosystems, Inc. in the Healthcare sector is trading at $0.87 with a market capitalization of $56M. Wall Street consensus targets $5.75 (4 analysts), implying a +558.0% move over the next 12 months. The stock is currently near its 52-week low of $0.83, remaining 63.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.05M↑ | $8.00M↓ | $11.28M↑ | $7.84M↑ | $7.26M |
| Gross Profit | $1.21M↑ | $371,000↑ | -$328,000↓ | $696,000↑ | $275,000 |
| Operating Income | -$12.32M↑ | -$13.85M↓ | -$12.21M↓ | -$11.37M↑ | -$12.15M |
| Net Income | -$12.92M↑ | -$14.28M↓ | -$12.50M↓ | -$11.51M↑ | -$11.86M |
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switze...